Group One Trading
AVTX icon

Group One Trading’s Avalo Therapeutics AVTX Stock Holding History

Group One Trading’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$16 – 7631
2025
Q4 		$18 Sell
1
-280
-100% -$4.73K ﹤0.01% 7957
2025
Q3 		$3.57K Buy
281
+280
+28,000% +$2.41K ﹤0.01% 7697
2025
Q2 		$5 Sell
1
-1
-50% -$5 ﹤0.01% 7831
2025
Q1 		$16 Hold
2
– – ﹤0.01% 7446
2024
Q4 		$15 Hold
2
– – ﹤0.01% 7143
2024
Q3 		$19 Hold
2
– – ﹤0.01% 6516
2024
Q2 		$25 Hold
2
– – ﹤0.01% 6586
2024
Q1 		$44 Hold
2
– – ﹤0.01% 6868
2023
Q4 		$18 Buy
2
+1
+100% +$23 ﹤0.01% 7249
2023
Q3 		$21 Hold
1
– – ﹤0.01% 7522
2023
Q2 		$62 Hold
1
– – ﹤0.01% 7535
2023
Q1 		$305 Hold
1
– – ﹤0.01% 6959
2022
Q4 		$931 Hold
1
– – ﹤0.01% 6848
2022
Q3 		$1K Hold
1
– – ﹤0.01% 7267
2022
Q2 		$1K Sell
1
-1
-50% -$1.34K ﹤0.01% 7512
2022
Q1 		$4K Hold
2
– – ﹤0.01% 7512
2021
Q4 		$9K Sell
2
-1
-33% -$6K ﹤0.01% 7384
2021
Q3 		$18K Sell
3
-2
-40% -$16.2K ﹤0.01% 7227
2021
Q2 		$50K Buy
5
+1
+25% +$8.38K ﹤0.01% 6573
2021
Q1 		$33K Buy
+4
New +$37.8K ﹤0.01% 6482
2020
Q3 		– Hold
0
– – – 6058
2020
Q2 		– Hold
0
– – – 5777
2020
Q1 		– Hold
0
– – – 5235

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Group One Trading's AVTX Position: Q1 2026 in Review

Group One Trading sold out of Avalo Therapeutics (AVTX) in Q1 2026, closing a stake of 1 share — an estimated $16 sold.

Group One Trading first reported a position in AVTX in Q1 2021 and held it in 20 quarters. The position peaked at $50K in Q2 2021. 97 funds tracked by Wall St. Rank hold AVTX as of Q1 2026.

  • Group One Trading reported no remaining Avalo Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 1 Avalo Therapeutics share in Q1 2026, an estimated $16.
  • Group One Trading first reported a position in Avalo Therapeutics in Q1 2021 and held it in 20 quarters.
  • Group One Trading's Avalo Therapeutics position peaked at $50K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.